SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
26-Feb-21 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Feb-21 | Sale (Planned) | 3,028 | $213.38 | $646,125.00 | (9%) 33.87K to 30.84K | |
26-Feb-21 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-21 | Payment of Exercise | 2,416 | $217.57 | $525,649.00 | (7%) 36.28K to 33.87K | |
19-Feb-21 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 18-Feb-21 | Sale (Planned) | 7,825 | $211.83 | $1,657,560.00 | (18%) 44.11K to 36.28K | |
19-Feb-21 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-21 | Payment of Exercise | 6,240 | $211.75 | $1,321,320.00 | (12%) 50.35K to 44.11K | |
16-Feb-21 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-Feb-21 | Private Sale (Planned) | 4,318 | $210.56 | $909,179.00 | (8%) 54.66K to 50.35K | |
12-Feb-21 4:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-21 | Payment of Exercise | 2,563 | $214.16 | $548,892.00 | (4%) 57.23K to 54.66K | |
09-Feb-21 7:44 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Feb-21 | Option Exercise | 1,930 | $86.52 | $166,984.00 | 3% 57.23K to 59.16K | |
09-Feb-21 7:44 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Feb-21 | Planned Option Sale | 1,930 | $215.00 | $414,950.00 | (3%) 59.16K to 57.23K | |
05-Feb-21 4:52 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-21 | Grant | 30,389 | -- | -- | 113% 26.84K to 57.23K | |
05-Feb-21 4:52 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-21 | Option Exercise | 400 | $86.52 | $34,608.00 | < 1% 57.23K to 57.63K | |
05-Feb-21 4:52 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-21 | Planned Option Sale | 400 | $216.56 | $86,624.00 | (< 1%) 57.63K to 57.23K | |
18-Nov-20 4:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Nov-20 | Private Sale (Planned) | 91 | $223.52 | $20,340.80 | (< 1%) 26.93K to 26.84K | |
06-Nov-20 4:09 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-Nov-20 | Option Exercise | 2,330 | $86.52 | $201,592.00 | 9% 26.84K to 29.17K | |
06-Nov-20 4:09 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-Nov-20 | Planned Option Sale | 2,330 | $217.74 | $507,329.00 | (8%) 29.17K to 26.84K | |
10-Aug-20 4:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Aug-20 | Option Exercise | 1,223 | $155.57 | $190,262.00 | 5% 26.84K to 28.06K | |
10-Aug-20 4:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Aug-20 | Planned Option Sale | 1,223 | $271.20 | $331,672.00 | (4%) 28.06K to 26.84K | |
05-Aug-20 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Aug-20 | Option Exercise | 2,330 | $86.52 | $201,592.00 | 9% 26.84K to 29.17K | |
05-Aug-20 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Aug-20 | Planned Option Sale | 2,330 | $278.28 | $648,402.00 | (8%) 29.17K to 26.84K | |
15-Jul-20 4:41 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Jul-20 | Option Exercise | 2,125 | $90.29 | $191,866.00 | 8% 26.84K to 28.96K | |
15-Jul-20 4:41 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Jul-20 | Planned Option Sale | 2,125 | $292.05 | $620,610.00 | (7%) 28.96K to 26.84K | |
19-May-20 4:28 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-May-20 | Private Sale (Planned) | 68 | $284.39 | $19,338.90 | (< 1%) 26.91K to 26.84K | |
13-May-20 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-May-20 | Option Exercise | 1,304 | $187.53 | $244,539.00 | 5% 26.84K to 28.14K | (10%) |
13-May-20 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-May-20 | Planned Private Option Sale | 1,304 | $286.00 | $372,944.00 | (5%) 28.14K to 26.84K | |
08-May-20 4:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-May-20 | Option Exercise | 1,222 | $155.57 | $190,107.00 | 5% 26.84K to 28.06K | |
08-May-20 4:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-May-20 | Planned Option Sale | 1,222 | $272.64 | $333,165.00 | (4%) 28.06K to 26.84K | |
06-May-20 4:25 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-May-20 | Option Exercise | 2,330 | $86.52 | $201,592.00 | 9% 26.84K to 29.17K | |
06-May-20 4:25 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-May-20 | Planned Option Sale | 2,330 | $260.87 | $607,827.00 | (8%) 29.17K to 26.84K | |
01-May-20 4:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Apr-20 | Option Exercise | 2,125 | $90.29 | $191,866.00 | 8% 26.84K to 28.96K | |
01-May-20 4:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Apr-20 | Planned Option Sale | 2,125 | $254.95 | $541,769.00 | (7%) 28.96K to 26.84K | |
26-Feb-20 4:35 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Feb-20 | Sale (Planned) | 3,028 | $233.49 | $707,005.00 | (10%) 29.87K to 26.84K | |
26-Feb-20 4:35 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-20 | Payment of Exercise | 2,416 | $239.23 | $577,980.00 | (7%) 32.28K to 29.87K | |
19-Feb-20 4:36 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 18-Feb-20 | Sale (Planned) | 3,128 | $243.61 | $762,020.00 | (9%) 35.41K to 32.28K | |
19-Feb-20 4:36 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-20 | Payment of Exercise | 2,496 | $241.50 | $602,784.00 | (7%) 37.91K to 35.41K | |
12-Feb-20 5:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-Feb-20 | Sale (Planned) | 16,882 | $246.11 | $4,154,830.00 | (31%) 54.79K to 37.91K | |
12-Feb-20 5:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-20 | Payment of Exercise | 13,458 | $240.95 | $3,242,700.00 | (20%) 68.25K to 54.79K | |
07-Feb-20 4:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-20 | Option Exercise | 2,526 | $172.06 | $434,614.00 | 4% 68.25K to 70.77K | |
07-Feb-20 4:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-20 | Planned Option Sale | 2,526 | $239.42 | $604,783.00 | (4%) 70.77K to 68.25K | |
07-Feb-20 4:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Feb-20 | Grant | 36,693 | -- | -- | 116% 31.55K to 68.25K | |
04-Feb-20 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-20 | Option Exercise | 2,330 | $86.52 | $201,592.00 | 7% 33.66K to 35.99K | |
04-Feb-20 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-20 | Planned Option Sale | 2,330 | $231.14 | $538,563.00 | (6%) 35.99K to 33.66K | |
04-Feb-20 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-20 | Sale (Planned) | 2,106 | $231.14 | $486,787.00 | (6%) 33.66K to 31.55K | |
04-Feb-20 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Jan-20 | Payment of Exercise | 1,344 | $231.21 | $310,746.00 | (3%) 38.91K to 37.57K | |
04-Feb-20 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Jan-20 | Option Exercise | 3,909 | $187.53 | $733,055.00 | 11% 35.0K to 38.91K | (10%) |
04-Feb-20 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Jan-20 | Planned Option Sale | 3,909 | $238.65 | $932,883.00 | (10%) 37.57K to 33.66K | |
24-Jan-20 4:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 22-Jan-20 | Option Exercise | 1 | $187.53 | $187.53 | < 1% 35.0K to 35.0K | (10%) |
24-Jan-20 4:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 22-Jan-20 | Planned Private Option Sale | 1 | $237.50 | $237.50 | (< 1%) 35.0K to 35.0K | |
15-Jan-20 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Jan-20 | Option Exercise | 2,125 | $90.29 | $191,866.00 | 6% 35.0K to 37.13K | |
15-Jan-20 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Jan-20 | Planned Option Sale | 2,125 | $226.78 | $481,910.00 | (6%) 37.13K to 35.0K | |
08-Jan-20 4:11 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Jan-20 | Option Exercise | 4,250 | $122.45 | $520,412.00 | 12% 35.0K to 39.25K | |
08-Jan-20 4:11 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Jan-20 | Planned Option Sale | 4,250 | $222.00 | $943,514.00 | (11%) 39.25K to 35.0K |